Introduction: The prenatal diagnosis of fetal craniosynostosis is challenging, especially in single-suture cases. When sutures are obliterated, sound waves fail to penetrate the cortical bone, creating an evident acoustic shadow on the underlying brain. The objective of this study was to evaluate the yield of the ‘brain shadowing sign' (BSS) as a novel sonographic marker for craniosynostosis. Subjects and Methods: Patients with an antenatal diagnosis of fetal craniosynostosis (cases) and healthy controls paired for gestational age were enrolled in this retrospective case-control study. Two-dimensional scans were assessed by three examiners for the presence of the BSS and additional fetal findings. Results: The BSS was clearly depicted in all 24 cases on the first analysis and in 22 cases on the second analysis. No fetus from the control group (n = 48) presented the BSS in any of the analyses. Fifteen cases had isolated craniosynostosis and 9 were syndromic (Apert, Saethre-Chotzen and craniofrontonasal syndromes), which were diagnosed significantly earlier due to additional malformations. Discussion: The BSS is a novel sonographic marker of craniosynostosis which can be used to increase the diagnostic rate of this rare condition and does not require the use of high-definition three-dimensional transducers to be depicted.

Keywords:
Craniosynostosis, Prenatal diagnosis, Fetal neurosonography, Sagittal synostosis, Fetal anomalies, Fetal brain
1.
Keating RF: Craniosynostosis: diagnosis and management in the new millennium. Pediatr Ann 1997;26:600-612.
2.
Johnson D, Wilkie AOM: Craniosynostosis. Eur J Hum Genet 2011;19:369-376.
3.
Sanders RD: Craniosynostosis; in Sanders RD, Blackman LR, Hogge A, Wulfsberg EA, Spevak MD (eds): Structural Fetal Abnormalities: The Total Picture, ed 2. London, Elsevier, 2002, p 33.
4.
Delahaye S, Bernard JP, Renier D, Ville Y: Prenatal ultrasound diagnosis of fetal craniosynostosis. Ultrasound Obstet Gynecol 2003;21:347-353.
5.
Fjørtoft MI, Sevely A, Boetto S, Kessler S, Sarramon MF, Rolland M: Prenatal diagnosis of craniosynostosis: value of MR imaging. Neuroradiology 2007;49:515-521.
6.
Pooh RK, Nakagawa Y, Pooh KH, Nagamachi N: Fetal craniofacial structure and intracranial morphology in a case of Apert syndrome. Ultrasound Obstet Gynecol 1999;13:274-280.
7.
Starr JR, Collett BR, Gaither R, Kapp-Simon KA, Cradock MM, Cunningham ML, Speltz ML: Multicenter study of neurodevelopment in 3-year-old children with and without single-suture craniosynostosis. Arch Pediatr Adolesc Med 2012;166:536-542.
8.
Benacerraf BR, Spiro R, Mitchell AG: Using three-dimensional ultrasound to detect craniosynostosis in a fetus with Pfeiffer syndrome. Ultrasound Obstet Gynecol 2000;16:391-394.
9.
Krakow D, Santulli T, Platt LD: Use of three-dimensional ultrasonography in differentiating craniosynostosis from severe fetal molding. J Ultrasound Med 2001;20:427-431.
10.
STROBE checklist for cohort, case-control, and cross-sectional studies. 2007. Available at: http://www.strobe-statement.org/index.php?id=available-checklists.
11.
International Society of Ultrasound in Obstetrics & Gynecology Education Committee: Sonographic examination of the fetal central nervous system: guidelines for performing the ‘basic examination' and the ‘fetal neurosonogram'. Ultrasound Obstet Gynecol 2007;29:109-116.
12.
Miller C, Loksen HW, Towbin R, Bowen A, Mooney MP, Towbin A, Faix RS: Ultrasound diagnosis of craniosynostosis. Cleft Palate Craniofac J 2002;39:73-80.
13.
Nørgaard P, Hagen CP, Hove H, Dunø M, Nissen KR, Kreiborg S, Jørgensen FS: Crouzon syndrome associated with acanthosis nigricans: prenatal 2D and 3D ultrasound findings and postnatal 3D CT findings. Acta Radiol Short Rep 2012;1:15.
14.
David AL, Turnbull C, Scott R, Freeman J, Bilardo CM, van Maarle M, Chitty LS: Diagnosis of Apert syndrome in the second-trimester using 2D and 3D ultrasound. Prenat Diagn 2007;27:629-632.
15.
Boog G, Le Vaillant C, Winer N, David A, Quere MP, Nomballais MF: Contribution of tridimensional sonography and magnetic resonance imaging to prenatal diagnosis of Apert syndrome at mid-trimester. Fetal Diagn Ther 2014;14:20-23.
16.
Mahieu-Caputo D, Sonigo P, Amiel J, Simon I, Aubry MC, Lemerrer M, Delezoïde AL, Gigarel N, Dommergues M, Dumez Y: Prenatal diagnosis of sporadic Apert syndrome: a sequential diagnostic approach combining three-dimensional computed tomography and molecular biology. Fetal Diagn Ther 2014;16:10-12.
17.
Kirmi O, Lo S, Johnson D, Anslow P: Craniosynostosis: a radiological and surgical perspective. Semin Ultrasound CT MR 2009;30:492-512.
18.
Lattanzi W, Bukvic N, Barba M, Tamburrini G, Bernardini C, Michetti F, Di Rocco C: Genetic basis of single-suture synostoses: genes, chromosomes and clinical implications. Childs Nerv Syst 2012;28:1301-1310.
19.
Meilstrup JW, Botti JJ, MacKay DR, Johnson DL: Prenatal sonographic appearance of asymmetric craniosynostosis: a case report. J Ultrasound Med 1995;14:307-310.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.